Provided by Tiger Fintech (Singapore) Pte. Ltd.

Nkarta

1.77
-0.0500-2.75%
Post-market: 1.770.00000.00%18:21 EDT
Volume:416.46K
Turnover:741.79K
Market Cap:125.59M
PE:-1.17
High:1.83
Open:1.83
Low:1.76
Close:1.82
Loading ...

Nkarta Inc. CEO Paul J. Hastings Reports Disposal of Common Shares

Reuters
·
Yesterday

Nkarta price target lowered to $14 from $16 at Mizuho

TIPRANKS
·
10 Jun

Nkarta Names Shawn Rose as Chief Medical Officer

MT Newswires Live
·
07 Jun

Nkarta Announces Leadership Change with New CMO

TIPRANKS
·
06 Jun

Nkarta appoints Shawn Rose as CMO, head of R&D

TIPRANKS
·
06 Jun

Nkarta Appoints Shawn Rose Chief Medical Officer & Head of R&D as Company Resets Senior Leadership Role for Autoimmune Focus

THOMSON REUTERS
·
06 Jun

Nkarta’s Strategic Enhancements in NKX019 Program and Trial Expansion Drive Positive Buy Rating

TIPRANKS
·
19 May

William Blair Downgrades Nkarta to Market Perform From Outperform

MT Newswires Live
·
15 May

Nkarta Is Maintained at Buy by Needham

Dow Jones
·
15 May

Nkarta Cut to Market Perform From Outperform by William Blair

Dow Jones
·
15 May

Nkarta Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
15 May

Nkarta reports Q1 EPS (43c), consensus (45c)

TIPRANKS
·
15 May

Nkarta Q1 EPS $(0.43) Beats $(0.44) Estimate

Benzinga
·
15 May

BRIEF-Nkarta Q1 Net Income USD -31.983 Million

Reuters
·
15 May

Nkarta Inc - Cash Balance of $351.9 Mln Expected to Fund Operations Into 2029

THOMSON REUTERS
·
15 May

Nkarta Q1 Cash & Investments USD 351.9 Million

THOMSON REUTERS
·
15 May

Nkarta Q1 Net Income USD -31.983 Million

THOMSON REUTERS
·
15 May

Nkarta Inc expected to post a loss of 44 cents a share - Earnings Preview

Reuters
·
08 May

Nkarta (NKTX) Upgraded to Buy: Here's Why

Zacks
·
15 Apr

Nkarta Price Target Maintained With a $11.00/Share by Needham

Dow Jones
·
09 Apr